For example, when L-NAME, a compound that inhibits NOS and reduces NO production, was administered, BPC-157 seemed to mitigate some of the resulting pathology
For when blends versus separate vials make sense, see When Do You Actually Need a Peptide Blend
Consistent availability of essential peptides for your experiments
BPC-157 demonstrates effective gastroprotection when delivered orally in models of colitis and gastric ulceration. Drmic, D
Versand und Bearbeitung erfolgen nach Zahlungs- und Bestellbesttigung
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)